MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan
· Delayed Price · Currency is TWD 6.57
-0.26 (-3.81%)
Apr 29, 2026, 2:00 PM CST
MARX Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -83.01 | -96.83 | -12.92 | 2.83 | 4.43 |
| Depreciation & Amortization | 20.98 | 17.43 | 4.57 | 1.95 | - |
| Other Amortization | 1.14 | 0.54 | 0.02 | - | - |
| Loss (Gain) From Sale of Assets | - | - | - | 0.1 | - |
| Loss (Gain) on Equity Investments | - | - | - | - | -4.97 |
| Provision & Write-off of Bad Debts | -2.14 | 7.61 | 2.89 | 0.99 | - |
| Other Operating Activities | -1.12 | -1.11 | -5.82 | -2.04 | -0.14 |
| Change in Accounts Receivable | 43.1 | -26.77 | -40.84 | 5.04 | - |
| Change in Inventory | -105.1 | -84.92 | -6.65 | -2.98 | - |
| Change in Accounts Payable | 40.74 | 65.06 | 3.13 | -1.05 | 0.89 |
| Change in Unearned Revenue | -77.52 | 10.34 | 14.82 | - | - |
| Change in Other Net Operating Assets | 16.94 | 1.45 | 23.66 | 6.59 | 0.11 |
| Operating Cash Flow | -145.67 | -107.18 | -17.13 | 11.44 | 0.31 |
| Operating Cash Flow Growth | - | - | - | 3566.35% | - |
| Capital Expenditures | -210.49 | -206 | -1.04 | -0.7 | - |
| Sale of Property, Plant & Equipment | 0.24 | 0.24 | - | - | - |
| Cash Acquisitions | -114.77 | -67.67 | -72.39 | 0.18 | - |
| Sale (Purchase) of Intangibles | -11.62 | -12.56 | -0.7 | - | - |
| Investment in Securities | -2 | -3.5 | - | - | - |
| Other Investing Activities | 2.36 | 3.01 | -0.97 | -0.28 | -0.05 |
| Investing Cash Flow | -336.28 | -286.48 | -75.1 | -0.79 | -0.05 |
| Short-Term Debt Issued | - | 98 | - | 10 | - |
| Long-Term Debt Issued | - | 170.31 | - | - | - |
| Total Debt Issued | 388.26 | 268.31 | - | 10 | - |
| Short-Term Debt Repaid | - | - | -25.99 | - | - |
| Long-Term Debt Repaid | - | -2.81 | -1.85 | -1.7 | - |
| Total Debt Repaid | -28.32 | -2.81 | -27.85 | -1.7 | - |
| Net Debt Issued (Repaid) | 359.94 | 265.5 | -27.85 | 8.3 | - |
| Issuance of Common Stock | 50 | 50 | 251.76 | - | - |
| Common Dividends Paid | - | - | -6.59 | -7.35 | - |
| Financing Cash Flow | 409.94 | 315.5 | 217.33 | 0.95 | - |
| Net Cash Flow | -72 | -78.16 | 125.1 | 11.6 | 0.27 |
| Free Cash Flow | -356.16 | -313.18 | -18.17 | 10.74 | 0.31 |
| Free Cash Flow Growth | - | - | - | 3343.27% | - |
| Free Cash Flow Margin | -49.96% | -50.66% | -6.27% | 9.71% | - |
| Free Cash Flow Per Share | -0.71 | -0.63 | -0.06 | 0.03 | 0.01 |
| Cash Interest Paid | 7.93 | 2.21 | 0.37 | 0.11 | - |
| Cash Income Tax Paid | - | 0.08 | 4.65 | 4.12 | - |
| Levered Free Cash Flow | -381.83 | -292.53 | -58.58 | -38.72 | - |
| Unlevered Free Cash Flow | -376.44 | -291.14 | -58.34 | -38.65 | - |
| Change in Working Capital | -81.84 | -34.83 | -5.88 | 7.61 | 0.99 |
Source: S&P Capital IQ. Standard template. Financial Sources.